Prostate cancer develops when cells in the prostate gland accumulate DNA damage that causes them to grow and divide uncontrollably. Up to 60% of prostate cancer risk comes from inherited factors, making genetics the single largest contributor. But the full picture involves a mix of biology, hormones, age, lifestyle, and environmental exposures that interact over decades.
How Prostate Cancer Starts at the Cell Level
Every prostate cancer begins with DNA damage in one or more prostate cells. Normally, your cells have built-in repair systems and self-destruct mechanisms that catch errors and prevent runaway growth. When enough of these safeguards break down, a cell starts dividing without the usual checks, eventually forming a tumor.
One of the clearest examples of this process involves bacterial infection. Research from Johns Hopkins has traced a detailed chain of events: certain bacteria that infect the prostate produce a toxin called colibactin, which directly breaks both strands of a cell’s DNA. This damage can cause two genes that should remain separate (TMPRSS2 and ERG) to fuse together abnormally. That fusion is found in roughly half of all prostate cancers and is considered one of the earliest events in tumor formation. Researchers found bacterial infections, the gene fusions, areas of inflammatory damage, and tiny buds of cancer all in the same location within prostate tissue, essentially a snapshot of the disease being born.
Hormones also play a direct role in fueling growth. Testosterone and a more potent form called dihydrotestosterone (DHT) enter prostate cells and activate a protein called the androgen receptor. Once switched on, this receptor tells the cell to turn on growth-promoting genes. This is why both normal and cancerous prostate cells depend on male hormones to grow, and why blocking those hormones is a standard treatment strategy.
Genetics and Family History
Inherited gene changes are the biggest single category of risk. Studies estimate that prostate cancer heritability is as high as 57%, meaning more than half of the variation in who gets the disease can be traced to genetic differences passed down through families. Several specific genes are known to increase risk substantially when they carry harmful mutations, including BRCA1, BRCA2, ATM, PALB2, and CHEK2. Some of these same genes are well known for raising breast and ovarian cancer risk in women, which is why a family history of those cancers on the same side of the family is also a red flag for prostate cancer.
Genetic testing is generally recommended for men with prostate cancer who have a close relative diagnosed with prostate cancer before age 60, a close relative with metastatic prostate cancer, three or more relatives on the same side of the family with breast or prostate cancer, or Ashkenazi Jewish ancestry. These patterns suggest a hereditary syndrome rather than a coincidence.
Having a father or brother with prostate cancer roughly doubles your own risk. The more relatives affected, and the younger they were at diagnosis, the higher your personal risk climbs.
Age Is the Strongest Single Risk Factor
Prostate cancer is overwhelmingly a disease of older men. The median age at diagnosis is 68, and the disease is rare before age 40. This is partly because DNA damage accumulates over a lifetime. Each time a prostate cell divides, there’s a small chance of copying errors. Over decades, these errors stack up, and the repair systems themselves become less reliable. Hormonal exposure over many years also contributes, since prostate cells are continuously stimulated by testosterone throughout a man’s life.
Race and Ethnicity
Black men in the United States have the highest prostate cancer incidence of any racial or ethnic group, at roughly 202 cases per 100,000 men, compared to significantly lower rates in other groups. They are also more likely to be diagnosed with aggressive forms of the disease. The reasons are both biological and social. Genetic variations that affect how the body processes hormones and repairs DNA differ across populations, and social inequities in access to healthcare, screening, and treatment contribute to worse outcomes. CDC data show that these disparities in survival are partly tied to diagnostic timing and social determinants of health rather than biology alone.
Chronic Inflammation and Infection
Long-term inflammation in the prostate creates an environment where cancer is more likely to develop. When bacteria or other irritants cause repeated cycles of tissue damage and repair, cells divide more frequently, raising the odds of DNA errors. Chronic inflammation also produces reactive molecules that can directly damage DNA.
This process can create a specific type of lesion in the prostate called proliferative inflammatory atrophy, where damaged tissue tries to regenerate but does so abnormally. These lesions are considered a precursor to early cancer in many cases. Observational studies have found that regular use of anti-inflammatory medications like aspirin or ibuprofen may lower prostate cancer risk, likely by dampening the chronic inflammatory signals that drive this process.
Obesity and Body Weight
Carrying excess weight is linked to a higher risk of aggressive prostate cancer specifically. Research shows an 8% to 11% increased risk of advanced prostate cancer and death from the disease in obese men. For every 5-unit increase in BMI (roughly the difference between a BMI of 27 and 32), the risk of advanced disease rises about 6%. The connection likely involves hormonal changes that come with obesity: fat tissue alters the balance of testosterone, estrogen, and insulin in ways that can promote tumor growth. Obesity also creates a state of low-grade chronic inflammation throughout the body, adding another layer of risk.
Interestingly, obesity appears to be more strongly linked to aggressive, fast-growing prostate cancers than to slow-growing ones. This means that while a heavier man may not be more likely to develop any prostate cancer, the cancer he does develop is more likely to be dangerous.
Chemical and Environmental Exposures
Certain chemical exposures have documented links to prostate cancer. The most studied is Agent Orange, the herbicide used extensively during the Vietnam War. The National Academy of Sciences has concluded there is suggestive evidence linking herbicide exposure to prostate cancer, and a 2013 study at the Portland VA Medical Center found that exposed veterans were not only at higher risk but more likely to develop aggressive forms. The U.S. Department of Veterans Affairs recognizes prostate cancer as a service-connected condition for veterans with documented Agent Orange exposure.
Occupational exposure to cadmium (found in battery manufacturing, welding, and some industrial processes) and certain pesticides has also been studied, though the evidence is less definitive than for Agent Orange. Firefighters, who are exposed to a complex mix of combustion byproducts, have shown elevated prostate cancer rates in several studies as well.
What Prostate Cancer Risk Means in Practice
Despite being one of the most common cancers in men, prostate cancer caught early has an excellent outlook. The 5-year survival rate for prostate cancer that hasn’t spread beyond the prostate or nearby lymph nodes is effectively 100%. Even for disease that has spread to distant parts of the body, the 5-year survival rate is about 40%, and treatments continue to improve.
Most of the risk factors for prostate cancer, including age, race, and genetics, are things you can’t change. The modifiable factors that matter most are maintaining a healthy weight, staying physically active, and being aware of your family history so you can have informed conversations about screening. If you have multiple close relatives with prostate, breast, ovarian, or pancreatic cancer, genetic counseling can help clarify whether you carry one of the high-risk gene mutations that would warrant earlier or more frequent monitoring.